Caterina Cancrini Selected Research

Cytochrome B-Negative Autosomal Recessive Chronic Granulomatous Disease

1/2022

Neonatal Manifestations of Chronic Granulomatous Disease: MAS/HLH and Necrotizing Pneumonia as Unusual Phenotypes and Review of the Literature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Caterina Cancrini Research Topics

Disease

11	Infections 01/2022 - 03/2002
6	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2021 - 10/2010
4	Lymphopenia (Lymphocytopenia) 01/2022 - 01/2017
4	Cytopenia 01/2020 - 01/2018
4	Ectodermal Dysplasia (Aplasia Cutis Congenita) 01/2018 - 10/2003
3	Virus Diseases (Viral Diseases) 02/2022 - 11/2015
3	Agammaglobulinemia (Hypogammaglobulinemia) 01/2022 - 01/2020
3	COVID-19 01/2022 - 11/2020
3	Disease Progression 12/2021 - 03/2002
3	Neoplasms (Cancer) 12/2021 - 01/2021
3	IgA Deficiency 01/2021 - 12/2002
3	Severe combined immunodeficiency due to adenosine deaminase deficiency 01/2020 - 10/2010
3	Bacterial Infections (Bacterial Infection) 01/2019 - 10/2003
2	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 01/2021
2	Opportunistic Infections (Opportunistic Infection) 01/2021 - 01/2019
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2021
2	Evans Syndrome 01/2020 - 07/2019
2	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2020 - 07/2019
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2020 - 07/2019
2	Exanthema (Rash) 07/2019 - 02/2010
2	Job Syndrome (Hyper-IgE Syndrome) 07/2019 - 02/2010
2	hypohidrotic Ectodermal dysplasia with immune deficiency 01/2018 - 10/2003
2	Wiskott-Aldrich Syndrome 02/2013 - 04/2009
1	Autoimmune Polyendocrinopathies (Schmidt Syndrome) 06/2022
1	Cytochrome B-Negative Autosomal Recessive Chronic Granulomatous Disease 01/2022
1	Necrotizing Pneumonia 01/2022
1	Hereditary Complement Deficiency Diseases 01/2022
1	Chronic Granulomatous Disease 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Histiocytosis 01/2022
1	Macrophage Activation Syndrome 01/2022
1	Stomach Neoplasms (Stomach Cancer) 12/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021
1	Eosinophilia 02/2021
1	Diplopia (Double Vision) 01/2021
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2021
1	Visceral Leishmaniasis (Kala Azar) 01/2021
1	Persistent Infection 01/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2021
1	Down Syndrome (Down's Syndrome) 01/2021
1	Headache (Headaches) 01/2021
1	Type 1 Hyper-IgM Immunodeficiency Syndrome 01/2021
1	Psychomotor Agitation (Akathisia) 12/2020
1	Dizziness (Lightheadedness) 12/2020
1	Arthritis (Polyarthritis) 12/2020
1	Aphthous Stomatitis (Aphthous Ulcer) 12/2020
1	Arthralgia (Joint Pain) 12/2020
1	Chemical and Drug Induced Liver Injury 12/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Cryptorchidism (Undescended Testes) 01/2020
1	Neutropenia 07/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Failure to Thrive 01/2019
1	Poliomyelitis (Polio) 01/2019
1	Viremia 01/2019

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 02/2022 - 04/2009
5	Immunoglobulin M (IgM)IBA 01/2022 - 12/2002
5	Immunoglobulin E (IgE)IBA 02/2021 - 02/2010
4	SteroidsIBA 01/2022 - 12/2015
3	VaccinesIBA 01/2021 - 09/2016
3	LigandsIBA 01/2021 - 10/2003
3	EnzymesIBA 12/2020 - 10/2012
3	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 01/2013
3	I-kappa B KinaseIBA 07/2010 - 10/2003
2	Immunoglobulin G (IgG)IBA 01/2021 - 12/2002
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021 - 01/2021
2	Rituximab (Mabthera)FDA Link 01/2020 - 07/2019
2	AntibodiesIBA 09/2018 - 11/2015
2	Serine (L-Serine)FDA Link 01/2018 - 10/2003
2	Adenosine DeaminaseIBA 10/2012 - 06/2011
2	NF-KappaB Inhibitor alphaIBA 07/2006 - 10/2003
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2006 - 05/2005
2	NF-kappa B (NF-kB)IBA 07/2006 - 10/2003
1	remdesivirIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2022
1	Abatacept (Orencia)FDA Link 12/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 12/2021
1	CD40 Ligand (CD40L)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Biological ProductsIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	seletalisibIBA 12/2020
1	pegademase bovine (pegADA)FDA Link 01/2020
1	NectinsIBA 07/2019
1	Intravenous Immunoglobulins (IVIG)FDA Link 07/2019
1	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 01/2019

Therapy/Procedure

7	Therapeutics 06/2022 - 12/2017
4	Transplantation 01/2021 - 07/2006
4	Hematopoietic Stem Cell Transplantation 01/2021 - 07/2006
2	Cell Transplantation 07/2019 - 10/2012
2	Stem Cell Transplantation 04/2017 - 07/2006
1	Precision Medicine 06/2022
1	Gastrectomy 12/2021
1	Bridge Therapy 01/2021
1	Orchiopexy 01/2020
1	Immunotherapy 07/2019